NewcelX Ltd. (NCEL) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Zurich, Switzerland. The current CEO is Ronen Twito.
NCEL has IPO date of 2025-10-24, 11 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $1.13M.
No company description available.
